Researcher.Life Logo

Cancer Drug Resistance : Impact Factor & More

eISSN: 2578-532X

Key Metrics

CiteScore
3
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Cancer Drug Resistance

Cancer Drug Resistance Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher OAE Publishing

Planning to publish in Cancer Drug Resistance ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Cancer Drug Resistance

Paired single cell analysis reveals chemotherapy resistance in osteosarcoma
  • 21 Apr 2026
  • Cancer Drug Resistance
Ultrasonic modulation of brain glymphatic transport: from observations to theranostic applications
  • 21 Apr 2026
  • Cancer Drug Resistance
Nanomaterial-based strategies overcome PD-1 related intrinsic immune resistance
  • 21 Apr 2026
  • Cancer Drug Resistance
Conjugated oligoelectrolytes overcome cancer drug resistance by dual-mode lysosomal membrane disruption.
  • 20 Mar 2026
  • Cancer drug resistance (Alhambra, Calif.)
From EGFR PTM network to TKI resistance: spatial subtypes and targeting in lung cancer.
  • 6 Mar 2026
  • Cancer drug resistance (Alhambra, Calif.)
TROP2-targeting antibody-drug conjugates in breast cancer and ovarian carcinoma: therapeutic advances and resistance mechanisms.
  • 25 Feb 2026
  • Cancer drug resistance (Alhambra, Calif.)
Paired single cell analysis reveals chemotherapy resistance in osteosarcoma
  • 21 Apr 2026
  • Cancer Drug Resistance
Ultrasonic modulation of brain glymphatic transport: from observations to theranostic applications
  • 21 Apr 2026
  • Cancer Drug Resistance
Nanomaterial-based strategies overcome PD-1 related intrinsic immune resistance
  • 21 Apr 2026
  • Cancer Drug Resistance
Conjugated oligoelectrolytes overcome cancer drug resistance by dual-mode lysosomal membrane disruption.
  • 20 Mar 2026
  • Cancer drug resistance (Alhambra, Calif.)
From EGFR PTM network to TKI resistance: spatial subtypes and targeting in lung cancer.
  • 6 Mar 2026
  • Cancer drug resistance (Alhambra, Calif.)
TROP2-targeting antibody-drug conjugates in breast cancer and ovarian carcinoma: therapeutic advances and resistance mechanisms.
  • 25 Feb 2026
  • Cancer drug resistance (Alhambra, Calif.)

FAQs on Cancer Drug Resistance